Why COVID-19 patients who could most benefit from Paxlovid still aren’t getting it
American Nurse
MARCH 13, 2024
Those who are receiving information more passively have no idea whether it’s important or harmful,” said Michael Barnett, a primary care physician at Brigham and Women’s Hospital and an associate professor at Harvard, who led the JAMA Network study. About That $1,390 List Price Pfizer sold the U.S. government 23.7
Let's personalize your content